
JAMA Network Open published results of the prespecified secondary analysis of data from the PANOVA-3 trial of Novocure’s TTFields therapy concomitant with gemcitabine and nab-pac in patients with unresectable, locally advanced pancreatic adenocarcinoma: investor.novocure.com/news-r…















